Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Queensland Health
Deloitte
McKesson
Cantor Fitzgerald
Accenture
Chinese Patent Office
Moodys
Dow

Generated: December 17, 2018

DrugPatentWatch Database Preview

FABRAZYME Drug Profile

« Back to Dashboard

Summary for Tradename: FABRAZYME
Pharmacology for FABRAZYME
Ingredient-typealpha-Glucosidases

US Patents for FABRAZYME

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Genzyme FABRAZYME agalsidase beta VIAL; INTRAVENOUS 103979 002 2003-04-24 ➤ Try a Free Trial Orphazyme ApS (Kobenhavn N, DK) ➤ Try a Free Trial RX Orphan search
Genzyme FABRAZYME agalsidase beta VIAL; INTRAVENOUS 103979 002 2003-04-24 ➤ Try a Free Trial Protalix Ltd. (Carmiel, IL) ➤ Try a Free Trial RX Orphan search
Genzyme FABRAZYME agalsidase beta VIAL; INTRAVENOUS 103979 002 2003-04-24 ➤ Try a Free Trial SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) ➤ Try a Free Trial RX Orphan search
Genzyme FABRAZYME agalsidase beta VIAL; INTRAVENOUS 103979 002 2003-04-24 ➤ Try a Free Trial SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) ➤ Try a Free Trial RX Orphan search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for FABRAZYME

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
/2010 Austria ➤ Try a Free Trial PRODUCT NAME: AGALSIDASE ALPHA; REGISTRATION NO/DATE: EU/1/01/189/001 20010803
20/2010 Austria ➤ Try a Free Trial PRODUCT NAME: AGALSIDASE ALPHA
13/054 Ireland ➤ Try a Free Trial PRODUCT NAME: AGALSIDASE BETA; REGISTRATION NO/DATE: EU/1/01/188/001-006 20010803
10/021 Ireland ➤ Try a Free Trial PRODUCT NAME: AGALSIDASE ALFA; NAT REGISTRATION NO/DATE: EU/1/01/188/001-003 20010803; FIRST REGISTRATION NO/DATE: EU/1/01/189/001 03/08/2001 EUROPEAN UNION EU/1/01/188/001-003 03/08/2001 EUROPEAN UNION EU/1/01/189/001 20010803
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
McKinsey
Mallinckrodt
Healthtrust
Colorcon
Covington
Queensland Health
Cantor Fitzgerald
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.